Toll-like receptor agonists regulate β-defensin 2 release in hair follicle

被引:16
|
作者
Selleri, S.
Arnaboldi, F.
Palazzo, M.
Gariboldi, S.
Zanobbio, L.
Opizzi, E.
Shirai, Y. F.
Balsari, A.
Rumio, C.
机构
[1] Univ Milan, Dept Human Morphol, I-20133 Milan, Italy
[2] Univ Milan, Inst Pathol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Mol Target Unit, I-20133 Milan, Italy
关键词
beta-defensin; 2; hair follicle; mouse; skin; toll-like receptor;
D O I
10.1111/j.1365-2133.2007.07899.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Skin is constantly in contact with different pathogens, which are present in the environment. The hair follicle is particularly susceptible to this microbial invasion as it offers an easy way of access for microorganisms; for this reason it is equipped with defence mechanisms to avoid frequent infections. Objectives To analyse the expression pattern of four different members of the toll-like receptor (TLR) family in murine hair follicles and to evaluate the effects of their activation by their specific microbiota-derived agonists, in terms of production of the antimicrobial peptide beta-defensin 2 (DEFB2). Methods TLR and DEFB2 protein expression was investigated by immunohistochemistry on murine skin samples. Results Murine hair follicle expresses TLR2, TLR4 and TLR5; agonists of TLR2, TLR4 and TLR5 but not of TLR9 induced DEFB2 production in this compartment. The strongest DEFB2 expression was observed following TLR4 activation by lipopolysaccharide. Conclusions Our data show that the hair follicle is equipped with TLR2, TLR4 and TLR5, and that these receptors are able to respond to microbial stimuli inducing the production of DEFB2 by epithelial cells. This immune response might be important in preserving the skin from microorganism infections.
引用
收藏
页码:1172 / 1177
页数:6
相关论文
共 50 条
  • [21] Toll-Like Receptor Agonists for Treatment of Viral Infections
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 153 - 154
  • [22] Plant lectins are novel Toll-like receptor agonists
    Unitt, John
    Hornigold, David
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (11) : 1324 - 1328
  • [23] Toll-Like Receptor Agonists as Adjuvants for HIV Vaccines
    Stevceva, L.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5079 - 5082
  • [24] Toll-like receptor 9 agonists as cancer therapeutics
    Holtick, Udo
    Scheulen, Max E.
    von Bergwelt-Baildon, Michael S.
    Weihrauch, Martin R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372
  • [25] Toll-Like Receptor Agonists: Not Just for Vaccines Anymore
    Tomai, Mark
    BIOPHARM INTERNATIONAL, 2011, 24 (01) : S15 - S16
  • [26] MICROGLIAL RESPONSES TO ENDOGENOUS TOLL-LIKE RECEPTOR AGONISTS
    Hanisch, U. K.
    Moeller, T.
    GLIA, 2009, 57 (13) : S6 - S6
  • [27] Toll-like receptors involved in the response to microbial pathogens: Development of agonists for toll-like receptor 9
    Schetter, C
    Vollmer, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 204 - 210
  • [28] Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2
    Biragyn, A
    Ruffini, PA
    Leifer, CA
    Klyushnenkova, E
    Shakhov, A
    Chertov, O
    Shirakawa, AK
    Farber, JM
    Segal, DM
    Oppenheim, JJ
    Kwak, LW
    SCIENCE, 2002, 298 (5595) : 1025 - 1029
  • [29] Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes
    He, HQ
    Genovese, KJ
    Nisbet, DJ
    Kogut, MH
    MOLECULAR IMMUNOLOGY, 2006, 43 (07) : 783 - 789
  • [30] Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells
    Parker, LC
    Whyte, MKB
    Vogel, SN
    Dower, SK
    Sabroe, I
    JOURNAL OF IMMUNOLOGY, 2004, 172 (08): : 4977 - 4986